Pharma company Amanta Healthcare has filed draft papers with the Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The company plans to issue up to 1.25 crore equity shares, each with a face value of ₹10. All shares will be fresh issues.
Purpose of Fundraising
Amanta plans to use the raised funds for several purposes, including:
- Funding capital expenditure for construction work.
- Purchasing equipment, plants, and machinery for a new manufacturing line for their product, SteriPort, at Hariyala in Kheda, Gujarat.
- Setting up a new Small Volume Parenteral (SVP) manufacturing line at the same location.
- Covering general corporate expenses.
Beeline Capital Advisors will act as the lead manager for the IPO, and Linktime Frame is the registrar for the issue.
About Amanta Healthcare
Amanta Healthcare Limited is a pharmaceutical company that develops, manufactures, and markets sterile liquid products. They use advanced technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) to create parenteral solutions for patients who need fast-absorbing medications but can’t take them orally.
Amanta produces large and small volume parenterals (LVPs and SVPs) across six therapeutic segments, including fluid therapy, eye care, respiratory care, and medical devices. Their Gujarat facility follows global Good Manufacturing Practices (GMP) standards, and they export products to 19 countries, holding 113 active international product registrations.
In India, Amanta markets over 45 generic products through 289 distributors. They also collaborate with other pharmaceutical companies to produce products at scale. The company is led by a team of experienced professionals dedicated to innovation and quality in healthcare.
Other IPO Filings
In addition to Amanta Healthcare, companies like All Time Plastics, Scoda Tubes, and Dev Accelerator (DevX) have also filed their draft papers with SEBI to launch their own IPOs.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
